GENETIC PREDICTORS OF FCHL IN 4 LARGE PEDIGREES - INFLUENCE OF APO-B LEVEL MAJOR LOCUS PREDICTED GENOTYPE AND LDL SUBCLASS PHENOTYPE

被引:80
作者
JARVIK, GP
BRUNZELL, JD
AUSTIN, MA
KRAUSS, RM
MOTULSKY, AG
WIJSMAN, E
机构
[1] UNIV WASHINGTON,DEPT EPIDEMIOL,DIV ENDOCRINOL & METAB,SEATTLE,WA 98195
[2] UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT GENET,SEATTLE,WA 98195
[3] UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195
[4] UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,BERKELEY,CA 94720
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1994年 / 14卷 / 11期
关键词
APO-B; LDL; GRADIENT GEL PHENOTYPE; FAMILIAL COMBINED HYPERLIPIDEMIA;
D O I
10.1161/01.ATV.14.11.1687
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The genetic basis of familial combined hyperlipidemia (FCHL) has eluded investigators for 20 years, despite the apparent segregation of FCHL as an autosomal dominant disorder affecting 1% to 2% of individuals. Etiologic heterogeneity and additive effects of traits controlled by other genetic loci have been suggested. Two traits have been implicated in FCHL. The first is the predominance of a small, dense low-density lipoprotein (LDL), LDL subclass phenotype B, which segregates as a mendelian trait. The second is a mendelian locus with large effects on apolipoprotein (ape) B levels that is defined by complex segregation analysis (predicted apoB level genotype). This study shows that these factors appear to be separate genetic effects, both of which aid in the prediction of FCHL in four large pedigrees. The results suggest that FCHL may be best predicted by a threshold model in which apoB level genotype and LDL subclass phenotype each act to increase the risk of FCHL. Heterogeneity in the transmission of apoB levels among families is suggested, supporting the etiologic heterogeneity of FCHL. These results emphasize the advantages inherent in the study of large pedigrees when disease heterogeneity is suspected.
引用
收藏
页码:1687 / 1694
页数:8
相关论文
共 61 条
  • [1] Akaike H, 1974, IEEE T AUTOMAT CONTR, V19, P719
  • [2] IMMUNOASSAY OF HUMAN PLASMA APOLIPOPROTEIN-B
    ALBERS, JJ
    CABANA, VG
    HAZZARD, WR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (12): : 1339 - 1351
  • [3] LINKAGE AND SEGREGATION ANALYSES OF APOLIPOPROTEIN-A1 AND APOLIPOPROTEIN-B, AND LIPOPROTEIN CHOLESTEROL LEVELS IN A LARGE PEDIGREE WITH EXCESS CORONARY HEART-DISEASE - THE BOGALUSA HEART-STUDY
    AMOS, CI
    ELSTON, RC
    SRINIVASAN, SR
    WILSON, AF
    CRESANTA, JL
    WARD, LJ
    BERENSON, GS
    [J]. GENETIC EPIDEMIOLOGY, 1987, 4 (02) : 115 - 128
  • [4] AUSTIN MA, 1988, AM J HUM GENET, V43, P838
  • [5] INHERITANCE OF LOW-DENSITY-LIPOPROTEIN SUBCLASS PATTERNS IN FAMILIAL COMBINED HYPERLIPIDEMIA
    AUSTIN, MA
    BRUNZELL, JD
    FITCH, WL
    KRAUSS, RM
    [J]. ARTERIOSCLEROSIS, 1990, 10 (04): : 520 - 530
  • [6] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
  • [7] ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK
    AUSTIN, MA
    KING, MC
    VRANIZAN, KM
    KRAUSS, RM
    [J]. CIRCULATION, 1990, 82 (02) : 495 - 506
  • [8] BIMODALITY OF PLASMA APOLIPOPROTEIN-B LEVELS IN FAMILIAL COMBINED HYPERLIPIDEMIA
    AUSTIN, MA
    HOROWITZ, H
    WIJSMAN, E
    KRAUSS, RM
    BRUNZELL, J
    [J]. ATHEROSCLEROSIS, 1992, 92 (01) : 67 - 77
  • [9] Austin Melissa A., 1993, Current Opinion in Lipidology, V4, P125, DOI 10.1097/00041433-199304000-00008
  • [10] AVOGARO P, 1978, ARTERY, V4, P385